Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A zinc-dependent ectopeptidase is a membrane-bound enzyme that utilizes a zinc ion (Zn²⁺) at its active site to catalyze the cleavage of peptide bonds, typically at the N-terminus of small peptides. These enzymes are often involved in various physiological processes, including peptide digestion, cell signaling, and regulation of bioactive peptides on the cell surface. A representative example is Aminopeptidase N (ANPEP/CD13), which is overexpressed in several cancers and acts as a receptor for some coronaviruses. Inhibition of these enzymes is being explored as a therapeutic strategy for cancer and viral infections.
Inhibition of ectopeptidase activity via zinc chelation or substrate/transition state mimicry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-dependent Ectopeptidase.